EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients

The aim of this study was to determine the frequency of EGFR, KRAS, BRAF, and HER-2 mutations in brain metastases from non-small cell lung carcinomas (BM-NSCLC). A total of 77 samples of BM-NSCLC were included and 19 samples of BM from breast, kidney, and colorectal tumors were also studied as contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Villalva, Claire, Duranton-Tanneur, Valérie, Guilloteau, Karline, Burel-Vandenbos, Fanny, Wager, Michel, Doyen, Jérôme, Levillain, Pierre Marie, Fontaine, Denys, Blons, Hélène, Pedeutour, Florence, Karayan-Tapon, Lucie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699841/
https://www.ncbi.nlm.nih.gov/pubmed/23930206
http://dx.doi.org/10.1002/cam4.82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699841/
https://www.ncbi.nlm.nih.gov/pubmed/23930206
http://dx.doi.org/10.1002/cam4.82

Ejemplares similares